Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2882
-0.0283 (-8.94%)
At close: May 13, 2026, 4:00 PM EDT
0.2666
-0.0216 (-7.49%)
After-hours: May 13, 2026, 7:59 PM EDT

Ensysce Biosciences Revenue

In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%. Ensysce Biosciences had revenue of $1.88M in the quarter ending December 31, 2025, with 44.39% growth.

Revenue (ttm)
$5.07M
Revenue Growth
-2.75%
P/S Ratio
0.53
Revenue / Employee
$506,665
Employees
10
Market Cap
2.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SciSparc856.00K
VivoSim Labs142.00K
Azitra7.50K
Virax Biolabs Group2.99K
Soligenix2.34K
Revenue Rankings